The global cell & gene therapy manufacturing services market is expected to reach USD 11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027. Growing prevalence of cancer and other other diseases, the surge in pharmaceutical R&D spending along with partnerships and agreements between pharmaceutical companies and CDMOs are some of the factors driving the market growth. On the...

"Europe Laboratory Developed Tests Market size and share is currently valued at USD 3.90 billion in 2023 and is anticipated to generate an estimated revenue of USD 7.59 billion by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust7.7% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032"...

Pragma Market Research and Business Consulting has published a new study titled "Viral Vector and Plasmid DNA Market: Size, Trends, and Insights" covering the market's dimensions, trends, and insights. Market Overview “According to the latest research study, the demand of global Viral Vector and Plasmid DNA Market size & share was valued at approximately US$ 667.5 million in 2023 and...

The global Advanced Therapy Medicinal Products (ATMP) CDMO Market was valued at USD 5.65 billion in 2023 and is projected to grow significantly to USD 26.27 billion by 2032, exhibiting a CAGR of 18.8% during the forecast period. The sharp growth is fueled by the rapid commercialization of cell therapies, gene therapies, and tissue-engineered...

The latest report entitled ‘Viral Vector, Non-Viral Vector and Gene Therapy Manufacturing Market’ by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe.   The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies...